Search Results for "Thrombin Injection For Pseudoaneurysm Cpt Code"

08:07 EDT 24th August 2016 | BioPortfolio

Matching Channels

Matching News

European Commission Approves Surgical Patch TachoSil® (human thrombin/human fibrogen) for Use in Neurological Surgery

Osaka, Japan, April 27, 2016 – Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted an expanded indication for surgical patch TachoSil (human t...

EXERCICE: 2 infirmières sur 3 hostiles au dextro fait par des aides-soignants - SNPI

Aujourd'hui, un aide-soignant ne peut effectuer d'injections, car "l'effraction de la barrière cutanée" relève du Code Pénal. Seul un médecin, et par d&eac...

Mylan introduces hydralazine HCl injection in US market

Mylan N.V., a global pharmaceutical company, has launched hydralazine hydrochloride injection USP, 20 mg/mL in US market, which is a generic version of Novartis' Apresoline injection, 20 mg/mL.

Milestone Scientific Schedules First Quarter 2016 Earnings Conference Call

LIVINGSTON, NJ--(Marketwired - May 16, 2016) - Milestone Scientific Inc. (NYSE: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovat...

AMA votes to modernize Code of Medical Ethics

The AMA has voted to adopt a modernized version of its Code of Medical Ethics, capping an 8-year process to update the guideline for relevance, clarity and consistency, according to a statement from t...

New adalimumab formulation associated with less injection site-related pain

Results recently presented at the EULAR Annual Congress showed a new formulation of adalimumab at 40 mg/0.4 mL in the treatment of rheumatoid arthritis was associated with less injection site-related ...

Milestone Scientific Schedules Second Quarter 2016 Earnings Conference Call

LIVINGSTON, NJ--(Marketwired - August 11, 2016) - Milestone Scientific Inc. (NYSE MKT: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innov...

BRIEF-Mylan launches generic vidaza injection

* Mylan NV says U.S. Launch of azacitidine for injection, 100 mg/vial, which is a generic version of Celgene's vidaza injection, 100 mg/vial Source text for Eikon: Further company coverage: (Ben...

Matching PubMed Articles

Percutaneous thrombin injection under sonographic guidance for exclusion of non-catheterizable post-pancreatitis pseudoaneurysm of the superior mesenteric artery: a minimally invasive and expeditious treatment option.

Post-pancreatitis pseudoaneurysms are not uncommon. They have a high associated mortality due to a propensity to rupture. Current standards of treatment advocate immediate intravascular interventions....

Ulnar pseudoaneurysm after transulnar coronary angiogram treated with percutaneous ultrasound-guided thrombin injection.

Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.

The purpose of this study was to clarify the precise effect of argatroban on the inhibition of cytokine secretion induced by thrombin on synovial cells. The efficiency of thrombin inactivation by thro...

Pulmonary Vein Pseudoaneurysm Secondary to Blunt Trauma: A Novel Management Strategy.

Traumatic pulmonary vein pseudoaneurysm is an extremely rare condition that is challenging to manage. We present a unique case of a pulmonary vein pseudoaneurysm from blunt trauma in a patient with pr...

Ruptured superior gluteal artery pseudoaneurysm with hemorrhagic shock: Case report.

Pseudoaneurysm of the superior gluteal artery (SGA) is very rare and the most common causes are blunt or penetrating pelvic traumas. Although pseudoaneurysm can be asymptomatic at the time of initial ...

Search Whole site using Google

Quick Search
Advertisement Advertisement